Skip to Content

MT 20 VIVUS (Pancreaze 21,000 USP units of lipase; 54,700 USP units of protease; 83,900 USP units of amylase)

Generic Name: pancrelipase

Pill with imprint MT 20 VIVUS is White, Capsule-shape and has been identified as Pancreaze 21,000 USP units of lipase; 54,700 USP units of protease; 83,900 USP units of amylase. It is supplied by Vivus, Inc..

Pancreaze is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancreaze 21,000 USP units of lipase; 54,700 USP units of protease; 83,900 USP units of amylase is not a controlled substance under the Controlled Substances Act (CSA).

Images for MT 20 VIVUS

Pancreaze

Generic Name
pancrelipase
Imprint
MT 20 VIVUS
Strength
21,000 USP units of lipase; 54,700 USP units of protease; 83,900 USP units of amylase
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Vivus, Inc.
Manufacturer
Nordmark Arzneimittel GmbH & Co. KG
National Drug Code (NDC)
62541-0405

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.